Gulf Coast TX
Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion
Oct 5 (Reuters) -- Swiss drugmaker Roche will pay up to $1.27 billion to license Alector's experimental treatment for Parkinson's disease, the US biotech said on Monday, sending it…
